139 related articles for article (PubMed ID: 33278022)
21. Use of intravenous N-acetylcysteine in acute severe hepatitis due to severe dengue infection: a case series.
Dissanayake DMDIB; Gunaratne WMSN; Kumarihamy KWMPP; Kularatne SAM; Kumarasiri PVR
BMC Infect Dis; 2021 Sep; 21(1):978. PubMed ID: 34544380
[TBL] [Abstract][Full Text] [Related]
22. Intraoperative pH values after N-acetylcysteine administration during liver transplantation.
Santiago FM; Olmedo C; Muffak-Granero K; Comino A; Villar JM; Garrote D; Bueno P; Ferrón JA
Transplant Proc; 2010 Oct; 42(8):3164-6. PubMed ID: 20970637
[TBL] [Abstract][Full Text] [Related]
23. Intravenous N-acetylcysteine improves transplant-free survival in early stage non-acetaminophen acute liver failure.
Lee WM; Hynan LS; Rossaro L; Fontana RJ; Stravitz RT; Larson AM; Davern TJ; Murray NG; McCashland T; Reisch JS; Robuck PR;
Gastroenterology; 2009 Sep; 137(3):856-64, 864.e1. PubMed ID: 19524577
[TBL] [Abstract][Full Text] [Related]
24. Intravenous N-acetylcysteine in pediatric patients with nonacetaminophen acute liver failure: a placebo-controlled clinical trial.
Squires RH; Dhawan A; Alonso E; Narkewicz MR; Shneider BL; Rodriguez-Baez N; Olio DD; Karpen S; Bucuvalas J; Lobritto S; Rand E; Rosenthal P; Horslen S; Ng V; Subbarao G; Kerkar N; Rudnick D; Lopez MJ; Schwarz K; Romero R; Elisofon S; Doo E; Robuck PR; Lawlor S; Belle SH;
Hepatology; 2013 Apr; 57(4):1542-9. PubMed ID: 22886633
[TBL] [Abstract][Full Text] [Related]
25. Early Use of N-acetylcysteine With Nitrate Therapy in Patients Undergoing Primary Percutaneous Coronary Intervention for ST-Segment-Elevation Myocardial Infarction Reduces Myocardial Infarct Size (the NACIAM Trial [N-acetylcysteine in Acute Myocardial Infarction]).
Pasupathy S; Tavella R; Grover S; Raman B; Procter NEK; Du YT; Mahadavan G; Stafford I; Heresztyn T; Holmes A; Zeitz C; Arstall M; Selvanayagam J; Horowitz JD; Beltrame JF
Circulation; 2017 Sep; 136(10):894-903. PubMed ID: 28634219
[TBL] [Abstract][Full Text] [Related]
26. Patterns of Early Allograft Dysfunction in Adult Live Donor Liver Transplantation: The A2ALL Experience.
Pomposelli JJ; Goodrich NP; Emond JC; Humar A; Baker TB; Grant DR; Fisher RA; Roberts JP; Olthoff KM; Gillespie BW; Merion RM
Transplantation; 2016 Jul; 100(7):1490-9. PubMed ID: 27326811
[TBL] [Abstract][Full Text] [Related]
27. Perioperative N-acetylcysteine to prevent renal dysfunction in high-risk patients undergoing cabg surgery: a randomized controlled trial.
Burns KE; Chu MW; Novick RJ; Fox SA; Gallo K; Martin CM; Stitt LW; Heidenheim AP; Myers ML; Moist L
JAMA; 2005 Jul; 294(3):342-50. PubMed ID: 16030279
[TBL] [Abstract][Full Text] [Related]
28. N-acetylcysteine enhances recovery from acute lung injury in man. A randomized, double-blind, placebo-controlled clinical study.
Suter PM; Domenighetti G; Schaller MD; Laverrière MC; Ritz R; Perret C
Chest; 1994 Jan; 105(1):190-4. PubMed ID: 8275731
[TBL] [Abstract][Full Text] [Related]
29. A graft to body weight ratio less than 0.8 does not exclude adult-to-adult right-lobe living donor liver transplantation.
Selzner M; Kashfi A; Cattral MS; Selzner N; Greig PD; Lilly L; McGilvray ID; Therapondos G; Adcock LE; Ghanekar A; Levy GA; Renner EL; Grant DR
Liver Transpl; 2009 Dec; 15(12):1776-82. PubMed ID: 19938139
[TBL] [Abstract][Full Text] [Related]
30. Prevention of contrast-induced nephropathy in vascular patients undergoing angiography: a randomized controlled trial of intravenous N-acetylcysteine.
Rashid ST; Salman M; Myint F; Baker DM; Agarwal S; Sweny P; Hamilton G
J Vasc Surg; 2004 Dec; 40(6):1136-41. PubMed ID: 15622367
[TBL] [Abstract][Full Text] [Related]
31. Lack of renoprotective effect of i.v. N-acetylcysteine in patients with chronic renal failure undergoing cardiac surgery.
Ristikankare A; Kuitunen T; Kuitunen A; Uotila L; Vento A; Suojaranta-Ylinen R; Salmenperä M; Pöyhiä R
Br J Anaesth; 2006 Nov; 97(5):611-6. PubMed ID: 16914459
[TBL] [Abstract][Full Text] [Related]
32. Usefulness of N-acetylcysteine or ascorbic acid versus placebo to prevent contrast-induced acute kidney injury in patients undergoing elective cardiac catheterization: a single-center, prospective, randomized, double-blind, placebo-controlled trial.
Brueck M; Cengiz H; Hoeltgen R; Wieczorek M; Boedeker RH; Scheibelhut C; Boening A
J Invasive Cardiol; 2013 Jun; 25(6):276-83. PubMed ID: 23735352
[TBL] [Abstract][Full Text] [Related]
33. Use of steatotic graft in living-donor liver transplantation.
Soejima Y; Shimada M; Suehiro T; Kishikawa K; Yoshizumi T; Hashimoto K; Minagawa R; Hiroshige S; Terashi T; Ninomiya M; Shiotani S; Harada N; Sugimachi K
Transplantation; 2003 Jul; 76(2):344-8. PubMed ID: 12883190
[TBL] [Abstract][Full Text] [Related]
34. Impact of Octreotide on Early Complications After Liver Transplant: A Randomized, Double-Blind Placebo-Controlled Trial.
Bagheri Lankarani K; Safa H; Ghahramani S; Sayari M; Malekhosseini SA
Exp Clin Transplant; 2022 Sep; 20(9):835-841. PubMed ID: 35867022
[TBL] [Abstract][Full Text] [Related]
35. Mannitol for prevention of acute kidney injury after liver transplantation: a randomized controlled trial.
Emara MM; Diab DG; Yassen AM; Abo-Zeid MA
BMC Anesthesiol; 2022 Dec; 22(1):393. PubMed ID: 36536282
[TBL] [Abstract][Full Text] [Related]
36. Renal Dysfunction After Liver Transplantation: Effect of Donor Type.
Kollmann D; Neong SF; Rosales R; Hansen BE; Sapisochin G; McCluskey S; Bhat M; Cattral MS; Lilly L; McGilvray ID; Ghanekar A; Grant DR; Selzner M; Wong FSH; Selzner N
Liver Transpl; 2020 Jun; 26(6):799-810. PubMed ID: 32189415
[TBL] [Abstract][Full Text] [Related]
37. Coexistence of Bilirubin ≥10 mg/dL and Prothrombin Time-International Normalized Ratio ≥1.6 on Day 7: A Strong Predictor of Early Graft Loss After Living Donor Liver Transplantation.
Okamura Y; Yagi S; Sato T; Hata K; Ogawa E; Yoshizawa A; Kamo N; Yamashiki N; Okajima H; Kaido T; Uemoto S
Transplantation; 2018 Mar; 102(3):440-447. PubMed ID: 28968350
[TBL] [Abstract][Full Text] [Related]
38. Risk factors, surgical complications and graft survival in liver transplant recipients with early allograft dysfunction.
Bastos-Neves D; Salvalaggio PRO; Almeida MD
Hepatobiliary Pancreat Dis Int; 2019 Oct; 18(5):423-429. PubMed ID: 30853253
[TBL] [Abstract][Full Text] [Related]
39. Effect of N-acetylcysteine pretreatment of deceased organ donors on renal allograft function: a randomized controlled trial.
Orban JC; Quintard H; Cassuto E; Jambou P; Samat-Long C; Ichai C
Transplantation; 2015 Apr; 99(4):746-53. PubMed ID: 25250647
[TBL] [Abstract][Full Text] [Related]
40. A descriptive analysis of aspartate and alanine aminotransferase rise and fall following acetaminophen overdose.
Curtis RM; Sivilotti ML
Clin Toxicol (Phila); 2015 Nov; 53(9):849-55. PubMed ID: 26294195
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
